NO20035235D0 - Farmasöytisk kombinasjon omfattende enten (S) -2-etoksy-3- (4- (2- (4-metansulfonyloksyfenyl) etoksy) fenyl) propansyre eller 3- (4- (2- (4-tert-butoksykarbonylaminofenyl) etoksy) fenyl) - Google Patents

Farmasöytisk kombinasjon omfattende enten (S) -2-etoksy-3- (4- (2- (4-metansulfonyloksyfenyl) etoksy) fenyl) propansyre eller 3- (4- (2- (4-tert-butoksykarbonylaminofenyl) etoksy) fenyl)

Info

Publication number
NO20035235D0
NO20035235D0 NO20035235A NO20035235A NO20035235D0 NO 20035235 D0 NO20035235 D0 NO 20035235D0 NO 20035235 A NO20035235 A NO 20035235A NO 20035235 A NO20035235 A NO 20035235A NO 20035235 D0 NO20035235 D0 NO 20035235D0
Authority
NO
Norway
Prior art keywords
ethoxy
phenyl
methanesulfonyloxyphenyl
butoxycarbonylaminophenyl
tert
Prior art date
Application number
NO20035235A
Other languages
English (en)
Inventor
Peter Oehman
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20035235D0 publication Critical patent/NO20035235D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20035235A 2001-06-01 2003-11-25 Farmasöytisk kombinasjon omfattende enten (S) -2-etoksy-3- (4- (2- (4-metansulfonyloksyfenyl) etoksy) fenyl) propansyre eller 3- (4- (2- (4-tert-butoksykarbonylaminofenyl) etoksy) fenyl) NO20035235D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101982A SE0101982D0 (sv) 2001-06-01 2001-06-01 Pharmaceutical combination
PCT/SE2002/001036 WO2002100413A1 (en) 2001-06-01 2002-05-30 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA

Publications (1)

Publication Number Publication Date
NO20035235D0 true NO20035235D0 (no) 2003-11-25

Family

ID=20284364

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035235A NO20035235D0 (no) 2001-06-01 2003-11-25 Farmasöytisk kombinasjon omfattende enten (S) -2-etoksy-3- (4- (2- (4-metansulfonyloksyfenyl) etoksy) fenyl) propansyre eller 3- (4- (2- (4-tert-butoksykarbonylaminofenyl) etoksy) fenyl)

Country Status (21)

Country Link
US (1) US20040157927A1 (no)
EP (1) EP1399166A1 (no)
JP (1) JP2004532891A (no)
KR (1) KR20040007624A (no)
CN (1) CN1250226C (no)
BR (1) BR0210127A (no)
CA (1) CA2448763A1 (no)
CO (1) CO5540382A2 (no)
CZ (1) CZ20033235A3 (no)
EE (1) EE200300583A (no)
HU (1) HUP0401613A3 (no)
IL (1) IL159035A0 (no)
IS (1) IS7057A (no)
MX (1) MXPA03011010A (no)
NO (1) NO20035235D0 (no)
PL (1) PL367890A1 (no)
RU (1) RU2003136157A (no)
SE (1) SE0101982D0 (no)
SK (1) SK14722003A3 (no)
WO (1) WO2002100413A1 (no)
ZA (1) ZA200309263B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6552055B2 (en) * 1996-12-11 2003-04-22 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I

Also Published As

Publication number Publication date
CA2448763A1 (en) 2002-12-19
EP1399166A1 (en) 2004-03-24
CO5540382A2 (es) 2005-07-29
IL159035A0 (en) 2004-05-12
CN1250226C (zh) 2006-04-12
WO2002100413A1 (en) 2002-12-19
IS7057A (is) 2003-11-28
KR20040007624A (ko) 2004-01-24
CZ20033235A3 (cs) 2004-12-15
SK14722003A3 (sk) 2004-08-03
RU2003136157A (ru) 2005-05-20
HUP0401613A2 (hu) 2004-11-29
SE0101982D0 (sv) 2001-06-01
US20040157927A1 (en) 2004-08-12
BR0210127A (pt) 2004-06-08
EE200300583A (et) 2004-02-16
MXPA03011010A (es) 2004-02-27
PL367890A1 (en) 2005-03-07
JP2004532891A (ja) 2004-10-28
HUP0401613A3 (en) 2007-11-28
ZA200309263B (en) 2005-03-11
CN1537008A (zh) 2004-10-13

Similar Documents

Publication Publication Date Title
LU92025I2 (fr) Méthanesulfonate d'éthylester d'acide 3-¬(2-{¬4-(hexyloxy-carbonylamino-imino-méthyl)-phénylamino-méthyl}-1-méthyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino-propionique
IS6399A (is) Mulið form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýloxýfenýl}etoxý)fenýl]própanónsýra
DK1237855T3 (da) Krystallinsk form af (S)-2-ethoxy-3-[4-(2-(4-methansulfonyloxyphenyl)ethoxy)phenyl]propansyre
NO2014011I2 (no) Vortioksetin eller et farmasøytisk akseptabelt syreaddisjonssalt dera
DK1438040T3 (da) Farmaceutiske sammensætninger indeholdende mycophenolsyre eller et mycophenolsalt
NO20023379D0 (no) Farmasöytisk preparat omfattende premetrexed sammen med monotioglycerol-L-cystein eller tioglykolsyre
DK1599455T3 (da) 4-(3-(2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butansyrederivater og beslægtede forbindelser som PPAR modulatorer til behandling af type 2 diabetes og aterosclerose
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
NO20035235D0 (no) Farmasöytisk kombinasjon omfattende enten (S) -2-etoksy-3- (4- (2- (4-metansulfonyloksyfenyl) etoksy) fenyl) propansyre eller 3- (4- (2- (4-tert-butoksykarbonylaminofenyl) etoksy) fenyl)
DE602004028500D1 (de) 4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga
NO20035236D0 (no) Farmasöytisk kombinasjon omfattende enten (S) -2-etoksy-3 (4- (2- (4-metansulfonyloksyfenyl) etoksy) fenyl) propansyre eller 3- (4- (2- (4-tert-butoksykarbonylaminofenyl) etoksy) fenyl) - (S) -2-
AU2034601A (en) Crystalline form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic acid
AU2034701A (en) Comminuted form of 3-(4-(2-(4-tert-butoxycarbonylaminophenyl)ethoxy)phenyl)-(s) 2-ethoxy propanoic
IS8234A (is) Kalíum- eða natríumsalt (-)-2-{[2-(4-hýdroxýfenýl)etýl]þíó}-3-[4-(2-{4-[(metýlsúlfónýl)oxý]fenoxý}fenýl]própansýru og notkun þeirra í læknisfræði
NO20035237D0 (no) Farmasöytisk kombinasjon omfattende enten (S) -2-etoksy-3-(4- (2- (4-metansulfonyloksyfenyl) etoksy) fenyl) propansyre eller 3- (4- (2- (4-tert-butoksykarbonylaminofenyl) etoksy) fenyl)
NO20043105L (no) Fremgangsmate for fremstilling av 2-(substituert fenyl)-2-hydroksy-etyl-karbamater
ATE348807T1 (de) Schwefelsäure mono-(3- (ä1-(2-(4-fluoro-phenyl)- ethyl)-piperidin-4-ylü -hydroxy-methyl)-2-methoxy-phenyl)ester
ATE466844T1 (de) (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-( - (2-(1,4,5,6-tetrahydropyrimidin-2- ylcarbamoyl)ethyl)benzoylamino)propion säureisopropylester, dessen herstellung und dessen verwendung
FR2868841B1 (fr) Methode d'identification de composes actifs sur la replication du virus hiv
ES1046049Y (es) "buje para la helice de un ventilador"

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application